BrickBuilt Therapeutics

BrickBuilt Therapeutics is developing novel treatments to improve oral health. Many diseases are downstream of oral health including periodontal disease, caries and oral candidiasis. BrickBuilt is developing live biotherapeutic products that can eliminate pathogens, disrupt their destructive factors and rebuild a healthy microbial community. Maintaining a healthy microbial community prevents the use of disease-inducing events such as antibiotic treatment and prolonged stress. BrickBuilt’s first preclinical candidate microbial drug targets periodontitis and will not only create a more effective way to eliminate gum disease but may reduce the risk of other conditions such as cardiovascular disease.

Jobs: